- April 1, 2009
- Company established
Ken Suzuki appointed as first president
- November 2009
- Commenced operation of Kyoto Logistics Center
First Medium-Term Management Plan
April 2010 to March 2013
- Medium-Term Vision
-
- Establish a competitive advantage in the pharmaceutical wholesale business and secure new growth opportunities
- April 2010
- Established VK Shared Service Co., Ltd., for the purpose of integrating head office functions
Second Medium-Term Management Plan
April 2013 to March 2016
- Medium-Term Vision
-
- Build a win-win relationship with customers in the pharmaceutical wholesale business
- Invest in businesses related to community-based comprehensive care systems and contribute to the construction of community healthcare infrastructure
- January 2014
- Acquired Finese Co., Ltd. as an equity-method affiliated company
- July 2014
- Made pharmacy chain OHNO CO. LTD. a consolidated subsidiary
- March 2015
- Commenced operation of Miyagi Logistics Center
- June 2015
- Taisuke Murai appointed as president
Third Medium-Term Management Plan
April 2016 to March 2019
- Medium-Term Vision
-
- Build a system that can generate profits, even in the era of 80% generic pharmaceuticals
- Build a foundation for the medical and nursing care collaboration business and deepen the level of community healthcare
- April 2017
- Acquired VK Shared Services Co., Ltd. by absorption-type merger
- May 2018
- Commenced operation of Hyogo Logistics Center
- May 2018
- Established Safuran Kids, a corporate-led childcare facility
- July 2018
- Established REED SPECIALITIES, INC.
- September 2018
- Signed capital and business partnership agreement with SanBio Co, Ltd.
Fourth Medium-Term Management Plan
April 2019 to March 2022
- Medium-Term Vision
-
- Become a corporate group chosen by customers
- May 2019
- Opened Sendai Robocare Center
- April 2020
- Made pharmacy chain Goodneighbor Inc. a consolidated subsidiary
- September 2020
- Commenced operation of Kawaguchi Logistics Center
- April 2021
- Made pharmacy chain Kenkodo Pharmacy Co., Ltd. a consolidated subsidiary
Fifth Medium-Term Management Plan
April 2022 to March 2025
- Medium-Term Vision
-
- Business model innovation with an eye to the next generation
- Main initiatives
-
- Pursuit of drug distribution model in keeping with market structure changes and market characteristics
- Evolution of distribution and marketing model in step with progress of DX in health care
- Implementation of group management that meets prime market requirements
- April 2022
- Start of the fifth Medium-Term Management Plan